HT
TEVA icon

HAP Trading’s Teva Pharmaceuticals TEVA Stock Holding History

HAP Trading’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-19,600
Closed -$2.06K – 1047
2023
Q4 		$2.06K Sell
19,600
-2,300
-11% -$21.5K ﹤0.01% 851
2023
Q3 		$10.4K Sell
21,900
-11,500
-34% -$107K ﹤0.01% 777
2023
Q2 		$27.1K Buy
33,400
+200
+0.6% +$1.62K ﹤0.01% 631
2023
Q1 		$27K Sell
33,200
-2,300
-6% -$22.7K ﹤0.01% 681
2022
Q4 		$18K Sell
35,500
-15,700
-31% -$137K ﹤0.01% 987
2022
Q3 		$67K Sell
51,200
-28,700
-36% -$254K ﹤0.01% 897
2022
Q2 		$137K Buy
79,900
+14,900
+23% +$130K 0.01% 816
2022
Q1 		$58K Buy
65,000
+6,600
+11% +$55.1K ﹤0.01% 1213
2021
Q4 		$129K Buy
58,400
+6,600
+13% +$59.6K ﹤0.01% 1153
2021
Q3 		$84K Sell
51,800
-800
-2% -$7.49K ﹤0.01% 1320
2021
Q2 		$89K Buy
+52,600
New +$557K ﹤0.01% 1264
2021
Q1 		– Sell
-108,700
Closed -$139K – 2356
2020
Q4 		$139K Buy
+108,700
New +$1.04M ﹤0.01% 1060
2020
Q3 		– Sell
-498,400
Closed -$152K – 1885
2020
Q2 		$152K Buy
+498,400
New +$5.64M 0.01% 760
2019
Q4 		– Sell
-117,100
Closed -$381K – 1476
2019
Q3 		$381K Buy
117,100
+51,800
+79% +$397K 0.03% 362
2019
Q2 		$230K Sell
65,300
-19,100
-23% -$230K 0.02% 474
2019
Q1 		$88K Buy
84,400
+44,700
+113% +$788K 0.01% 570
2018
Q4 		$87K Sell
39,700
-28,100
-41% -$576K 0.01% 666
2018
Q3 		$173K Sell
67,800
-29,900
-31% -$694K 0.01% 474
2018
Q2 		$131K Buy
97,700
+44,000
+82% +$897K 0.01% 530
2018
Q1 		$177K Sell
53,700
-20,900
-28% -$408K 0.01% 471
2017
Q4 		$171K Buy
74,600
+16,500
+28% +$248K 0.01% 520
2017
Q3 		$499K Buy
58,100
+35,100
+153% +$790K 0.02% 356
2017
Q2 		$76K Sell
23,000
-8,600
-27% -$266K ﹤0.01% 632
2017
Q1 		$108K Buy
31,600
+20,400
+182% +$696K 0.01% 562
2016
Q4 		$73K Sell
11,200
-6,700
-37% -$268K ﹤0.01% 609
2016
Q3 		$99K Sell
17,900
-272,200
-94% -$14.2M ﹤0.01% 590
2016
Q2 		$507K Buy
290,100
+277,000
+2,115% +$14.7M 0.03% 316
2016
Q1 		$44K Sell
13,100
-82,100
-86% -$4.82M ﹤0.01% 546
2015
Q4 		$24K Buy
95,200
+5,700
+6% +$352K ﹤0.01% 717
2015
Q3 		$433K Buy
89,500
+10,500
+13% +$681K 0.02% 391
2015
Q2 		$279K Buy
+79,000
New +$4.87M 0.02% 421
2014
Q2 		– Sell
-273,000
Closed -$19K – 1149
2014
Q1 		$19K Sell
273,000
-387,000
-59% -$17.9M ﹤0.01% 883
2013
Q4 		$1.33M Buy
660,000
+250,000
+61% +$9.84M 0.04% 359
2013
Q3 		$2.13M Hold
410,000
– – 0.07% 216
2013
Q2 		$1.88M Buy
+410,000
New +$16M 0.06% 250

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

HAP Trading's TEVA Position: Q3 2025 in Review

HAP Trading opened a new position in Teva Pharmaceuticals (TEVA) in Q3 2025: 14,492 shares worth $293K. The stake represents 0.02% of the portfolio and ranks #341 among its holdings. This is a return to the name: HAP Trading previously reported a position in TEVA as recently as Q4 2023.

HAP Trading first reported a position in TEVA in Q2 2013 and has held it in 31 quarters since. The position peaked at $129M in Q4 2014. 551 funds tracked by Wall St. Rank hold TEVA as of Q3 2025.

  • HAP Trading held 14,492 shares of Teva Pharmaceuticals worth $293K as of Q3 2025.
  • Teva Pharmaceuticals was a new HAP Trading position in Q3 2025.
  • Teva Pharmaceuticals made up 0.02% of HAP Trading's portfolio in Q3 2025, its #341 holding.
  • HAP Trading first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 31 quarters since.
  • HAP Trading's Teva Pharmaceuticals position peaked at $129M in Q4 2014.
  • 551 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2025.

Based on HAP Trading's 13F filing for Q3 2025, filed 12 Nov 2025.